| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ... The lancet Diabetes & endocrinology 9 (10), 653-662, 2021 | 1029 | 2021 |
| Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) MMY Lee, KJM Brooksbank, K Wetherall, K Mangion, G Roditi, ... Circulation 143 (6), 516-525, 2021 | 391 | 2021 |
| Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI … J Layland, KG Oldroyd, N Curzen, A Sood, K Balachandran, R Das, ... European heart journal 36 (2), 100-111, 2015 | 337* | 2015 |
| Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease JP Langrish, X Li, S Wang, MMY Lee, GD Barnes, MR Miller, FR Cassee, ... Environmental health perspectives 120 (3), 367-372, 2012 | 337 | 2012 |
| Adenosine: physiology, pharmacology, and clinical applications J Layland, D Carrick, M Lee, K Oldroyd, C Berry JACC: Cardiovascular Interventions 7 (6), 581-591, 2014 | 335 | 2014 |
| Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short-and long-term outcomes E Platz, RT Campbell, B Claggett, EF Lewis, JD Groarke, KF Docherty, ... JACC: Heart Failure 7 (10), 849-858, 2019 | 184 | 2019 |
| Diabetic cardiomyopathy MMY Lee, JJV McMurray, A Lorenzo-Almorós, SL Kristensen, N Sattar, ... Heart 105 (4), 337-345, 2019 | 124 | 2019 |
| Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes SL Kristensen, PS Jhund, MMY Lee, L Køber, SD Solomon, CB Granger, ... Cardiovascular drugs and therapy 31, 545-549, 2017 | 102 | 2017 |
| Statins in the prevention and treatment of heart failure: a review of the evidence MMY Lee, N Sattar, JJV McMurray, CJ Packard Current atherosclerosis reports 21, 1-8, 2019 | 96 | 2019 |
| Aficamten for symptomatic obstructive hypertrophic cardiomyopathy MS Maron, A Masri, ME Nassif, R Barriales-Villa, M Arad, N Cardim, ... New England Journal of Medicine 390 (20), 1849-1861, 2024 | 92 | 2024 |
| How couples who have undergone in vitro fertilization decide what to do with surplus frozen embryos RD Nachtigall, K Mac Dougall, J Harrington, J Duff, M Lee, G Becker Fertility and sterility 92 (6), 2094-2096, 2009 | 78 | 2009 |
| What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition RD Nachtigall, K Mac Dougall, M Lee, J Harrington, G Becker Fertility and sterility 94 (6), 2069-2072, 2010 | 69 | 2010 |
| Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction KF Docherty, RT Campbell, KJM Brooksbank, JG Dreisbach, P Forsyth, ... Circulation 144 (3), 199-209, 2021 | 61 | 2021 |
| Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type 2 diabetes MMY Lee, N Ghouri, DK McGuire, MK Rutter, N Sattar Diabetes Care 44 (5), 1236-1241, 2021 | 60 | 2021 |
| Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics SE Yeoh, J Osmanska, MC Petrie, KJM Brooksbank, AL Clark, ... European Heart Journal 44 (31), 2966-2977, 2023 | 59 | 2023 |
| How do SGLT2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists reduce cardiovascular outcomes? Completed and ongoing mechanistic … MMY Lee, MC Petrie, JJV McMurray, N Sattar Arteriosclerosis, thrombosis, and vascular biology 40 (3), 506-522, 2020 | 54 | 2020 |
| Heart failure with preserved ejection fraction: everything the clinician needs to know P Campbell, FH Rutten, MMY Lee, NM Hawkins, MC Petrie The Lancet 403 (10431), 1083-1092, 2024 | 47 | 2024 |
| Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis MMY Lee, KF Docherty, N Sattar, N Mehta, A Kalra, AS Nowacki, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (2), 165-178, 2022 | 46 | 2022 |
| Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial MMY Lee, SL Kristensen, HC Gerstein, JJV McMurray, N Sattar Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (1), 102382, 2022 | 33 | 2022 |
| Exercise capacity in patients with obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM baseline characteristics and study design CJ Coats, MS Maron, TP Abraham, I Olivotto, MMY Lee, M Arad, N Cardim, ... Heart Failure 12 (1), 199-215, 2024 | 29 | 2024 |
John McMurrayUniversity of Glasgow.Verifisert e-postadresse på glasgow.ac.uk
